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(Draft #4 8-29) Pharmacy 552 & 595 B.S. :  Therapeutics III (+) Fall 2001 
 
Lectures:   M-W-Th 1010-1100 Rm 114, Skaggs Building 
  F only  1010-1100 Rm 336, Skaggs Building 
  (note: joint lectures with Pharm.D class in SB114 or 117) 
  (note: 595 lectures on Weds 0910-1000 in SB 336) 
 
Course Coordinator: Michael Rivey  ====>  M. Rivey 
Instructors:   Douglas Allington         Office:  243-6796 
    Rose Macklin      Community Hosp: 728-4100 
    Cathy Bartels                 ext. 7605 
    Sarah Miller               Pager: 329-6122 
    Gayle Cochran   Home: 251-3369 
    Donna Beall  Larry Dent 
    Lee Ann Bradley Vince Colucci  
    William Docktor Tim Stratton       
Material and Resources 
 Required Texts: DiPiro Pharmacotherapy, 4th edition 
APhA:  Handbook of Nonprescription Drugs 
    Medical Letter on Drugs & Therapeutics 
    Goodman & Gilman's Pharmacological Basis of Therapeutics 
    Boh Pharmacy Practice Manual 
    A medical dictionary 
 
 Optional Texts: Murphy: Clinical Pharmacokinetics pocket reference 
    Evans:  Applied Pharmacokinetics 
    Young, Koda-Kimble:  Applied Therapeutics 
    Hansten & Horn:  Drug Interactions 
    Pagana & Pagana: Diagnostic & Lab Test Ref., or other lab. text 
      
Goals of the Course 
 
 To promote the students' understanding of common disease 
 states with particular emphasis on the facets of diseases 
 that are amenable to drug therapy. 
 
 To familiarize the student with the proper use of drugs in 
 a clinical setting. 
  
 To develop the students' awareness of factors that should be 
 considered prior to selection of a drug and the appropriate 
 parameters that should be monitored for therapeutic as well 
 as undesired effects. 
 
 To encourage the students' ability to problem-solve in the 
 clinical setting. 
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Performance Objectives 
 Upon completion of this course, each student shall be able to: 
 
 Relate the pathophysiology of a disease to the known or purported action of a drug. 
 
Evaluate the seriousness of a disorder based on the signs and symptoms related to a 
diagnosed problem, and: 
  --determine the necessity of drug therapy, 
  --when applicable, choose the proper drug and/or 
   drug product for the situation. 
 
 Determine the place of non-pharmacologic and natural therapies, when applicable. 
 
Tailor the drug therapy of an individual based on patient characteristics and known 
pharmacokinetics principles. 
 
 Identify potential drug-drug interactions. 
 
 Monitor the appropriate parameters of a disease to determine if the patient is responding 
positively to therapy. 
 
Monitor for adverse drug reactions and exacerbations of underlying patient problems 
resulting from drug therapy. 
 
Student Responsibilities and Obligations 
 
 * To attend and participate in lecture sessions. 
 
 * To do assigned readings from the texts. 
 
* To attend Integrated Studies conferences, prepare each case in advance, prepare to 
present a patient case, and participate in the discussion of all patient presentations. 
 
 * To perform satisfactorily on course quizzes and lecture examinations.   
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GRADING IN COURSE:  Phar 552-BS Therapeutics 
 
3 midterm exams: 100 points each                       300 points  
Final exam (comprehensive, multiple choice)                  130 points 
(100 pts comprehensive, 30 pts over last 6 lectures) 
Topic quizzes:  8 quizzes graded on 10 pts each   Bonus pts > 75% 
TOTAL POINTS FOR COURSE                                430 POINTS 
 
Class quizzes:  The purposes of the quizzes are to promote reading of the text before a topic.  
Quizzes will occur before topic lectures and will test understanding of basic concepts in the 
reading assignments. A quiz will consist of 5 multiple choice or true/false questions, each worth 
2 points.  QUIZ on syllabus indicates a quiz will be given for the overall topic at start of the given 
lecture and will concern only assigned reading for that day.  Lowest 2 quiz grades will be thrown 
out; no make-ups will be allowed for quiz.  Scoring:  Quiz performance can only benefit 
student; bonus points for the course will be awarded for all points over 75% (i.e. 60 pts) of the 
potential total 80 pts on the quizzes (10 total quizzes – 2 throw-outs = 8x10 pts) 
 
NOTE:  Reading assignments are from DiPiro (4th edition) & APhA books 
 
Integrated Studies Conferences: you will be assigned to a conference based on period you 
registered for; instructors are not necessarily the ones under which you registered.  
Attendance/make-up is required for all topics/cases; you may attend a different conference in 
order to complete the assignment, with instructor permission.  The “make-up” requirement for a 
conference will be at the discretion of the instructor, dependent on the topic. 
 
Exams: 
3 midterm exams:  Tests will be in "traditional" case report fashion with short answers required. 
 Tests will be given during a “common” time period.  B.S. and Pharm.D. classes will take tests 
simultaneously.   
 
Final exam:  65 multiple choice questions worth 2 pts each.  Effort will be made to design 
questions in the style similar to the NAPLEX exam. 
 
Class civility:  Your student colleagues have strongly indicated to us that they wish to spend 
their valuable time in class listening to therapeutics topics.  They do not appreciate any “side” 
conversations while the instructor is lecturing.  They do appreciate students raising questions 
about important lecture aspects for further discussion or clarification.   
 Out of respect for your classmates, we will not tolerate excessive and disruptive talking 
during lecture.  The instructor may first ask you to be silent; you may be asked to leave class if 
you persist in disruptive talking.  The instructor will be the judge of “what” constitutes disruption. 
 Please note that we encourage questions and relevant discussion. 
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Therapeutics III 552 B.S. & Phar 595 supplemental course: Lecture Syllabus 
   
         Instructor Reading 
Sept 5W Introduction/ Liver disease (9AM SB336) MPR (595) 35, 38   
 5W Liver disease       MPR  
 6Th Liver disease     MPR   
 7F Renal disease/ (10AM in SB 114)/ QUIZ DRA  40 
 
 10M Renal disease     DRA  42 
 12W Hypertension     LAD (595) JNC-6 download 
 12W HTN       LAD  10 
 13Th HTN       LAD   
 14F Pain Management (10 AM SB114)  LAB  56, OTC 18 
 
 17M Pain mgmt  (11AM SB117)   LAB 
 19W Drug Literature Evaluation   CLB (595) 
 19W Headache (11AM SB 117)/ QUIZ  DB  57 
 20Th Congestive Heart Failure    VJC  11 
 21F Headache (10AM SB 114)   DB  OTC 25 
 
 24M CHF       VJC   
 25T Career Fair 
 26W Drug Literature Evaluation   CLB (595)  
 26W CHF       VJC   
 27Th Digoxin kinetics     VJC 
 28F Coronary Artery Disease    VJC  12  
 
Oct  1M CAD       VJC   
  3W Drug Literature Evaluation   CLB (595) 
  3W Arthritis (11AM SB 117)/ QUIZ   MPR   84 
  4Th Arthritis      MPR   83 
  5F Arthritis (note!! 11AM SB 117)   MPR  OTC pp 71-2, OTC5 
  5 F   Test 1 at 1-3 PM in SB 114; through Dig PK 
 
  8M Gout (11AM SB 117)    MPR  85 
 10W Drug Literature Evaluation   CLB (595)  
 10W Hyperlipidemia     LAD  ATP III download  
 11Th Hyperlipidemia     LAD  19 
 12F Contraception (10AM SB114)/ QUIZ  DB  OTC 8 
 
 15M Contraception      DB  76    
 17W   Contraception     DB (595) 
 17W Dysrhythmias     VJC  14 
 18Th off day- no class 
 19F off; ASP-MRM meeting in Seattle 
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552-Ther III & Phar 595, continued 
 
Oct 22M Menopause (11AM SB 117)/ QUIZ  GAC  78 
 24W Drug Literature Evaluation   CLB (595) 
 24W Menopause (11 AM SB 117)   GAC 
 25Th Dementia       GAC  61 
 26F Osteoporosis (10 AM SB 114)   GAC  82, OTC 419-20 
 
 29M Osteoporosis (11AM SB 117)   GAC 
 31W Drug Literature Evaluation   CLB (595) 
 31W Obstructive Airways Disease/ QUIZ  DRA  24 
    (11AM SB 117) 
Nov   1Th Theophylline kinetics    DRA  
  2F OAD (10AM SB 114)    DRA  25, OTC 10  
  2F Test 2 at 1-3 PM n SB 114; through osteoporosis 
 
  5M Oncology overview    CLB  DiPiro pp.2013-41 5  7W
 Oncology overview    CLB (595)  
  7W Thromboembolic Disease (11AM SB 117) MPR  17  
  8Th TED       MPR 
  9F Stroke/ (10AM SB 114)/ QUIZ   MPR  18 
 
 12M VETERANS DAY HOLIDAY  
 14W Nausea & vomiting     LAB (595) 33, OTC 5 
 15W Seizure dx/ QUIZ     DRA   52 
 15Th Seizure disorders     DRA   
 16F Anticonvulsant kinetics     DRA  
        
 19M Fluid & electrolytes    SJM  DiPiro pp 890-902 
 21W OFF; TRAVEL DAY  
 22Th THANKSGIVING HOLIDAY 
 23F  “                    “ 
 
 26M F&E       SJM  pp 902-16 
 28W Biostatistics overview    TPS (595) 
 28W Nutrition      SJM 
 29Th Thyroid disorders     MPR  71 
 30F Diabetes mellitus/ QUIZ    LRM  70 
 
Dec 3M DM       LRM      
 5W Biostatistics overview    TPS (595) 
 5W DM tests      LRM  OTC 39 
 6Th Anxiety/sleep disorders       WJD  67,69, OTC 24 
   7F test 3 at 1-3 PM in SB 114; through nutrition 
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552-Ther III & Phar 595, continued 
 
 10M Attention deficit disorder   WJD  DiPiro pp. 1046-49 
 12W Biostatistics overview   TPS (595) 
 12W CLASS EVALUATION  
 13Th  Depression/ QUIZ    WJD  65 
 14F Depression     WJD 
 
Phar 552-BS Final:  test 4, 130 pts comprehensive multiple choice NAPLEX/PSAP format 
Phar 595 Final:  see below; biostatistics questions added to Final 
 
 
NOTE:  class will meet at 10AM or 11AM (if meeting together with Pharm.D. class) on 
days throughout the semester 
 
 
 
 
 
 
 
 
 
 
 
Pharmacy 595: supplemental course 
 
Phar 595:  Course is 1-hour Wednesday session to supplement Ther-III and cover other topics 
not in B.S. curriculum in an overview fashion.  It is graded course 
 
Schedule: merged to above syllabus (weekly on Weds at 0910-1100 in SB 336) 
 
Instructors: various Therapeutics instructors 
  Cathy Bartels 
  Tim Stratton 
 
 
Grading in Phar 595: 
 
6/14 of course grade: project in Drug Literature Evaluation 
3/14 of course grade: biostatistics questions on Final Exam (add-on questions) 
5/14 of course grade: grade obtained in Ther. Phar 552 course
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Integrated Studies Phar 574 
 
I. Conference topics 
 
Tuesday 0910-1100 SB335 Rivey 
Tuesday 0910-1100 SB337 Colucci 
 
week of: 
 
September  3M  no conference 
 
  10M  Liver disease case 
 
  17M  Hypertension case 
 
  24M  Headache/pain management 
 
October  1M  Digoxin kinetics 
 
   8M  J-club for ½ of class; service learning work session 
 
  15M  OTC cases 
 
  23M  Contraception 
 
  29M  service learning update: J-club for other ½ of class  
 
November  5M  SEMINARS 
  
  12M  OAD case 
 
  19M  off week- holiday week 
 
  26M  TED case 
 
December  3M  OTC cases 
 
  10M  Evaluation/ Diabetes case 
 
 
 
Seminar:  A required activity in the course, graded on a pass/no-pass basis.  Student must 
repeat a no-pass seminar to successfully pass course. 
 
